Annual cashflow statement for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.0630.02-2.52-0.038-0.04
Other Operating Cash Flow
Cash from Operating Activities0.01-0.008-6.19-0.112-0.124
Other Investing Cash Flow Items00-5.910.669-28.6
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities00-5.910.669-28.6
Financing Cash Flow Items00-0.27-0.697-0.672
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0012.2-0.55928.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.01-0.0080.057-0.002-0.024